Christopher M. Cabral Ph.D.
Chris's background in science allows him to help clients develop effective strategies for protecting their intellectual property. He counsels clients in all aspects of patent prosecution and patent counseling, including opinion work specific to freedom to operate, invalidity, non-infringement, patentability, and industry landscape analyses. Chris has developed patent portfolios for several developmental stage biologics and counsels clients on patent term extensions, adjustments, and FDA exclusivity.
Chris is well-versed in all phases of domestic and foreign patent prosecution, and his patent procurement experience involves preparing and prosecuting domestic and foreign patent applications for clients in the life science and chemical areas, with particular emphasis on the biotechnology, pharmaceutical, diagnostics, and small molecule arenas. Chris also has experience with a variety of post-grant proceedings including reexaminations, European oppositions, and inter partes reviews.
Chris's representative matters include:
- Successfully defended an inventorship challenge filed by a third party against a patent owned by a small molecule pharmaceutical company client at the district court and on appeal to the Federal Circuit.
- Prepared, prosecuted and managed complex United States and international patent portfolios covering selective progesterone receptor modifiers and selective estrogen receptor modifiers.
- Prepared, prosecuted and managed complex United States and international patent portfolios covering genetically modified microorganisms.
- Prepared, prosecuted and managed complex United States and international patent portfolios directed to gene therapy.
- Conducted non-infringement and invalidity opinions for international pharmaceutical manufacturers.
- Prepared, prosecuted and managed complex United States and international patent portfolios covering medical diagnostic methods for several molecular diagnostic companies.
- Counseled several biotechnology companies and maintained their United States and international patent portfolios directed to oncolytic viruses.
- American Bar Association
Chris has served on the Associate Board of the American Cancer Society since 2006. He also volunteers at Chicago Cares.